Microbot Medical
MBOT
26 hedge funds and large institutions have $974K invested in Microbot Medical in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.16% less ownership
Funds ownership: 0.37% → 0.21% (-0.16%)
4% less funds holding
Funds holding: 27 → 26 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
32% less capital invested
Capital invested by funds: $1.44M → $974K (-$461K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$62.6K |
| 2 |
BlackRock
New York
|
+$15.1K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.1K |
| 4 |
Invesco
Atlanta,
Georgia
|
+$10.1K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$1.22K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$612K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$68.4K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$33K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
-$13.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$13.2K |
MBOT Hedge Fund Activity: Q2 2018 in Review
26 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q2 2018, worth a combined $974K — down 32% from $1.44M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of MBOT and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Virtu Financial, opening a new position worth an estimated $62.6K. The largest seller was Sabby Management, cutting an estimated $612K.
- 26 institutional investors held Microbot Medical (MBOT) as of Q2 2018, down from 27 in Q1 2018.
- Funds reported $974K of Microbot Medical stock for Q2 2018, down 32% quarter-over-quarter.
- 3 funds opened new Microbot Medical positions in Q2 2018 and 4 closed out, a net change of -1 holder.
- The largest Microbot Medical buyer in Q2 2018 was Virtu Financial, an estimated $62.6K added.
- The largest Microbot Medical seller in Q2 2018 was Sabby Management, an estimated $612K sold.
Based on aggregated 13F filings for Q2 2018.